CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion | +29,670 | $10.36 | $307K | 99,592 |
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion | +4,994 | $11.10 | $55K | 104,586 |
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion | +3,723 | $11.97 | $45K | 108,309 |
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion | +3,144 | $12.97 | $41K | 111,453 |
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion | +2,595 | $15.52 | $40K | 114,048 |
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion · Share Option | −29,670 | 0 | ||
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion · Share Option | −4,994 | 54,936 | ||
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion · Share Option | −3,723 | 56,207 | ||
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion · Share Option | −3,144 | 38,256 | ||
| 2026-11-13 | Paolini John F. CHIEF MEDICAL OFFICER | Exercise or conversion · Share Option | −2,595 | 47,405 | ||
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion 10b5-1 | +11,280 | $17.76 | $200K | 23,977 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −11,280 | $98.54 | $1.1M | 12,697 |
| 2026-11-09 | Megna Michael R CHIEF ACCOUNTING OFFICER | Exercise or conversion · Share Option 10b5-1 | −11,280 | 5,114 | ||
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Exercise or conversion 10b5-1 | +145,763 | $17.92 | $2.6M | 925,800 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −1,460 | $92.35 | $135K | 924,340 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −11,335 | $93.54 | $1.1M | 913,005 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −81,742 | $94.20 | $7.7M | 831,263 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −29,845 | $95.48 | $2.8M | 801,418 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −26,918 | $96.05 | $2.6M | 774,500 |
| 2026-11-04 | Patel Sanj K CHAIRMAN & CEO | Exercise or conversion · Share Option 10b5-1 | −145,763 | 0 |
Page 1 of 81 · 1,605 trades